Clinical Trial Update: Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients [NA]

View source ↗

Summary

Telitacicept is being studied in a clinical trial to prevent flares in systemic lupus erythematosus, with recruitment ongoing at RenJi Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RenJi Hospital | Conditions: Systemic Lupus Erythematosus | NA | Status: RECRUITING